Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Treprostinil subcutaneous (under the skin) infusion is a very good medication for treating
pulmonary arterial hypertension but infusion site pain may be very severe in some patients.
The investigators plan to treat patients receiving treprostinil with a subcutaneous infusion
of lidocaine (a local anesthestic) to treat the pain.